BioCentury
ARTICLE | Clinical News

BA058-transdermal: Completed Phase II enrollment

January 14, 2013 8:00 AM UTC

Radius completed enrollment of 250 postmenopausal women with osteoporosis in a double-blind, placebo-controlled, international Phase II trial comparing 50, 100 and 150 µg BA058-TD once daily vs. once-...